AC Immune SA
F:IMR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AC Immune SA
F:IMR
|
CH |
|
K
|
Kodi Co Ltd
KOSDAQ:080530
|
KR |
|
M
|
Mercado Minerals Ltd
OTC:MRMNF
|
CA |
|
W
|
Wendel SE
F:WIS
|
FR |
|
Vente-Unique.Com SA
PAR:ALVU
|
FR |
|
P
|
PDF Solutions Inc
XMUN:PD9
|
US |
|
Cobalt Blue Holdings Ltd
F:COH
|
AU |
|
A
|
Akobo Minerals AB (publ)
OSE:AKOBO
|
SE |
|
Gold Flora Corp
OTC:GRAM
|
US |
|
Humana Inc
NYSE:HUM
|
US |
|
B
|
Brainchip Holdings Ltd
OTC:BRCHF
|
AU |
|
S
|
SPC Power Corp
XPHS:SPC
|
PH |
|
B
|
Bitfarms Ltd
TSX:BITF
|
CA |
|
B
|
BusinessOn Communication Co Ltd
KOSDAQ:138580
|
KR |
|
L
|
Lichen China Ltd
NASDAQ:LICN
|
CN |
|
S
|
Sichuan Hongda Co Ltd
SSE:600331
|
CN |
|
C
|
CTOS Digital Bhd
KLSE:CTOS
|
MY |
|
K
|
KohYoungTechnologyInc
KOSDAQ:098460
|
KR |
|
Enerflex Ltd
TSX:EFX
|
CA |
|
F
|
Ford Motor Co
DUS:FMC1
|
US |
|
P
|
Permian Resources Corp
DUS:YZ8
|
US |
Bankruptcy Probability
AC Immune SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AC Immune SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
AC Immune SA
NASDAQ:ACIU
|
273.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AC Immune SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AC Immune SA has total debt of 3.3m CHF. This includes both short-term (0 CHF) and long-term (3.3m CHF) debt.
You can find a full breakdown on its Balance Sheet.
